For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Bausch Health Companies Inc (NYSE: BHC) closed at $6.62 down -4.61% from its previous closing price of $6.94. In other words, the price has decreased by -$4.61 from its previous closing price. On the day, 3.4 million shares were traded. BHC stock price reached its highest trading level at $6.96 during the session, while it also had its lowest trading level at $6.58.
Ratios:
For a deeper understanding of Bausch Health Companies Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.35. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.
Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 08 ’25 when Carson Seana sold 13,370 shares for $7.31 per share. The transaction valued at 97,735 led to the insider holds 499,585 shares of the business.
Carson Seana bought 13,370 shares of BHC for $97,735 on Sep 08 ’25. On Aug 21 ’25, another insider, Lee Frank D., who serves as the Director of the company, sold 15,912 shares for $7.66 each. As a result, the insider received 121,886 and left with 73,795 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2564002816 and an Enterprise Value of 23107821568. As of this moment, Bausch’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.83, and their Forward P/E ratio for the next fiscal year is 1.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24. Its current Enterprise Value per Revenue stands at 2.304 whereas that against EBITDA is 7.032.
Stock Price History:
The Beta on a monthly basis for BHC is 0.40, which has changed by -0.21933961 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $9.12, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is 0.48%, while the 200-Day Moving Average is calculated to be 5.55%.
Shares Statistics:
For the past three months, BHC has traded an average of 2.80M shares per day and 3185030 over the past ten days. A total of 370.47M shares are outstanding, with a floating share count of 328.20M. Insiders hold about 11.42% of the company’s shares, while institutions hold 66.63% stake in the company. Shares short for BHC as of 1761868800 were 6478871 with a Short Ratio of 2.31, compared to 1759190400 on 7705899. Therefore, it implies a Short% of Shares Outstanding of 6478871 and a Short% of Float of 1.8900000000000001.
Earnings Estimates
. The current rating of Bausch Health Companies Inc (BHC) is the result of assessments by 5.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $0.77, with high estimates of $0.84 and low estimates of $0.65.
Analysts are recommending an EPS of between $4.01 and $3.72 for the fiscal current year, implying an average EPS of $3.89. EPS for the following year is $4.16, with 5.0 analysts recommending between $4.66 and $3.72.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $2.72B this quarter.It ranges from a high estimate of $2.76B to a low estimate of $2.68B. As of. The current estimate, Bausch Health Companies Inc’s year-ago sales were $2.56BFor the next quarter, 6 analysts are estimating revenue of $2.42B. There is a high estimate of $2.43B for the next quarter, whereas the lowest estimate is $2.41B.
A total of 6 analysts have provided revenue estimates for BHC’s current fiscal year. The highest revenue estimate was $10.23B, while the lowest revenue estimate was $10.15B, resulting in an average revenue estimate of $10.19B. In the same quarter a year ago, actual revenue was $9.62BBased on 6 analysts’ estimates, the company’s revenue will be $10.52B in the next fiscal year. The high estimate is $10.77B and the low estimate is $10.08B.
